Back

Predictors and clinical consequences of heart damage in CMR in patients after COVID-19

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: COVID-19 and cardiovascular disease in special populations Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Michal Chudzik

The Medical Centre of Postgraduate Education, Warsaw (Poland)

5 More presentations in this session

Presentation thumbnail
COVID-19 vaccine-induced myocarditis vs. Immune checkpoint inhibitor-induced myocarditis - Same but different?
Doctor M. Laufer-Perl (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Parameters of coagulation and platelet hyperreactivity reflect an increased mortality in patients with moderate to severe COVID-19
Mr K. Jakobs (Berlin, DE)
Abstract Slides
Presentation thumbnail
Galectin-3 as a possible marker for increased thrombogenicity in COVID-19
Ms M. Puccini (Berlin, DE)
Abstract Slides
Presentation thumbnail
Pragmatic observations from a post-Covid-19 cardiac evaluation register: prevalence of cardiological alterations from a basic diagnostic sequence and contribution of the clinical hystory.
Doctor G. Ruiz (Buenos Aires, AR)
Abstract Slides

Access the full session

Session thumbnail
COVID-19 and cardiovascular disease in special populations

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources